Table 4.
RA Persistent, | Other, | Univariate Analysis |
Binary Logistic Regression Analysis | ||
---|---|---|---|---|---|
n = 19 | n = 77 | p | OR (95% CI)* | p | |
Age, yrs, median (IQR) | 67 (59–74) | 41 (30–56) | < 0.001 | 1.08 (1.01–1.2) | 0.02 |
Female, % | 58 | 40 | 0.26 | 1.5 (0.3–8.7) | 0.65 |
Symptom duration > 6 weeks, % |
47 | 38 | 0.55 | 0.4 (0.05–3.4) | 0.41 |
EMS ≥ 1 h, % | 53 | 34 | 0.09 | 1.03 (0.1–7.4) | 0.98 |
Arthritis of ≥ 3 joint areas, % |
58 | 27 | 0.02 | 1.7 (0.2–12.2) | 0.62 |
Arthritis of wrist or MCP or PIP joints, % |
79 | 36 | 0.002 | 5.3 (0.7–42.1) | 0.11 |
Symmetrical arthritis, % | 37 | 21 | 0.27 | 10.2 (1.1–96.2) | 0.04 |
Subcutaneous nodules, % | 5 | 3 | 0.53 | 0.5 (0.01–24) | 0.72 |
RF ELISA positive and anti-CCP ELISA positive, % |
63 | 3 | < 0.001 | 79.6 (7.5–849.9) | < 0.001 |
For age, the odds ratio is per year-increase in age. EMS: early morning stiffness. MCP: metacarpophalangeal. PIP: proximal interphalangeal.